Editorial: Metabolic cell death in cancer: innovative therapeutic avenues for cancer treatment
-
By
-
Zhou Yang
-
Guang Lei
-
Yize Li
-
June 9, 2026
-
Clinical Scorecard: Exploring Novel Therapeutic Strategies Targeting Metabolic Cell Death in Oncology
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Metabolic reprogramming, nutrient utilization, redox balance, mitochondrial function, regulated cell death pathways. |
| Target Population | |
| Care Setting | |
Key Highlights
- Metabolic adaptations determine cellular susceptibility to regulated cell death.
- Serine dependency represents a metabolic liability in tumors.
- Hypoxia is a major driver of metabolic adaptation and therapeutic resistance.
- Ferroptosis and cuproptosis are potential therapeutic avenues.
- Genetic context shapes metabolic vulnerabilities in tumors.
Guideline-Based Recommendations
Diagnosis
- Precise molecular characterization of tumors is essential for understanding metabolic dependencies.
Management
- Targeting essential metabolic nodes can destabilize tumor homeostasis.
Monitoring & Follow-up
- Integrating metabolic profiling with cell death phenotyping is crucial.
Risks
- Therapeutic strategies must consider the context-dependent nature of metabolic vulnerabilities.
Patient & Prescribing Data
Patients with tumors exhibiting specific metabolic dependencies.
Therapies should aim to disrupt metabolic adaptation and reactivate cell death pathways.
Clinical Best Practices
- Utilize combinations of therapies to target metabolic adaptations.
- Monitor hypoxic conditions in tumors.
Related Resources & Content
